(Total Views: 117)
Posted On: 02/17/2023 11:40:45 AM
Post# of 124602
$MRK News Article - U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for Merck's PREVYMIS(TM) for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk https://marketwirenews.com/news-releases/u-s-...54726.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
